About Soul Pharma

Building Trusted Care Pathways Through Science, Access, and Execution.

Founded in 2003, Soul Pharma is a quality-first pharmaceutical organization focused on therapeutic relevance, responsible growth, and dependable availability across India.

2003

Founded

20+

Cities Presence

5+

Core Therapies

About Soul Pharma

Vision, Mission, and Responsibility

Vision

To become a globally respected pharmaceutical partner recognized for dependable quality and meaningful healthcare accessibility.

Mission

To deliver reliable, economical formulations with scientific rigor, regulatory discipline, and patient-centric execution.

CSR Commitments

To support healthcare education, equitable access, and environmentally responsible operations across communities we serve.

Milestone Timeline

A journey shaped by compliance, credibility, and market trust.

2003

Foundation and Quality Setup

Established Soul Pharma with a strong quality control framework and therapeutic focus.

2009

WHO Standards Compliance

Aligned core manufacturing and quality processes with WHO-oriented standards.

2011

NSIC-ONICRA SE-2B

Achieved credibility milestone reinforcing financial and operational confidence.

2016

CSR Excellence Recognition

Recognized for contributions in community-focused healthcare responsibility programs.

2023

Healthcare Partnership Excellence

Recognized for collaborative ecosystem growth with clinicians, distributors, and partners.

Manufacturing and Quality Discipline

We maintain consistent formulation integrity through robust vendor qualification, process controls, and post-market feedback loops.

  • WHO-aligned quality culture
  • Focused therapeutic depth
  • Evidence-driven product planning
  • Reliable availability strategy
Soul Pharma quality and manufacturing

Leadership Focus

Strategic Clarity

Leadership aligns scientific priorities, field realities, and long-term partner confidence.

Execution Excellence

Cross-functional discipline ensures product consistency, distribution stability, and market responsiveness.

Portfolio Intent

Focused presence in Neuro-Psychiatry, Gynecology, Orthopedics, Anti-Infectives, and Vitamins.

Ethics and Accountability

Every growth decision is grounded in responsible healthcare impact and compliance-first execution.